← Browse by Condition
Medical Condition
sarcoma synovial
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2
NCT07066982 Phase 1, Phase 2
Recruiting
Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas
Enrollment
60 pts
Location
China
Sponsor
Essen Biotech
NCT05296564 Phase 1, Phase 2
Recruiting
Anti-NY-ESO-1 TCR-Gene Engineered Lymphocytes Given by Infusion to Patients With NY-ESO-1 -Expressing Metastatic Cancers
Enrollment
3 pts
Location
Israel
Sponsor
Hadassah Medical Organization